Here we uncovered that downregulation of retinoic acid‐inducible gene I (RIG‐I)[18] as an HMA‐resistant mechanism underlying the failure of HMA in triggering IFN anticancer immune responses in AML cell lines, xenograft mice, and patient‐derived primary cells. The gene discussed is RIGI; the disease is acute myeloid leukemia.